Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05111015 · ClinicalTrials.gov registry record

Tracking Results of Ablations to Combat AF Registry Generation 2

A clinical trial of Atrial Fibrillation, sponsored by AtriCure.

Recruiting
Registry status
10,000
Enrollment target
20
Study locations

NCT05111015: Recruiting study of Atrial Fibrillation, sponsored by AtriCure.

NCT05111015 is a study of Atrial Fibrillation that is actively recruiting participants, run by AtriCure. The registered enrollment target is 10,000 participants, above the 2,947-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (239% higher). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05111015, a study of Atrial Fibrillation, is actively recruiting participants, sponsored by AtriCure.

RECRUITING
Registry status
10,000 participants
Enrollment target
20
Study locations

Study Summary

The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation.

Primary Outcome

Collect patient data on Atrial Fibrillation burden after the ablation procedure as documented by long term event monitoring or identified during the exam after a six-month recovery period.

Conditions Studied

Atrial Fibrillation

Interventions

  • DEVICE Open Concomitant Surgical Ablation Procedures
  • DEVICE Hybrid (Convergent) Ablation Procedures
  • DEVICE AtriCure Hybrid Totally Thoracoscopic Ablation Procedures
  • DEVICE AtriCure LAA Exclusion Procedures

Study Locations (20)

Florida

  • Delray Medical Center - Delray Beach
  • University of Florida - Gainesville
  • Orlando Health Heart & Vascular Institute - Orlando
  • St. Joseph's Hospital (BayCare) - Tampa

Arkansas

  • St. Bernards Medical Center - Jonesboro
  • CHI St. Vincent Heart Institute - Little Rock

California

  • Loma Linda University Medical Center - Loma Linda
  • Adventist Heart Institute (St. Helena Hospital) - St. Helena

Michigan

  • University of Michigan - Ann Arbor
  • Corewell Health - Grand Rapids

New York

  • Maimonides Health Heart & Vascular Institute - Brooklyn
  • Vassar Brothers Medical Center - Poughkeepsie

Alabama

  • Huntsville Hospital - Huntsville

Colorado

  • Valley View Hospital - Glenwood Springs

District of Columbia

  • MedStar Washington Hospital - Washington D.C.

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2013-02
Est. Completion 2030-01
AtriCure

23 total trials

What NCT05111015 shows while recruiting

NCT05111015 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 2,947-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (239% higher).

The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 4 interventions - of which Open Concomitant Surgical Ablation Procedures is the first listed.

NCT05111015 names 20 study sites across 13 states, led by Florida, Arkansas, California.

Frequently Asked Questions

What is clinical trial NCT05111015 about?

NCT05111015 is a clinical study titled "Tracking Results of Ablations to Combat AF Registry Generation 2". The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation.

What is the current status of trial NCT05111015?

This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2013-02. Estimated completion is 2030-01.

What conditions does trial NCT05111015 study?

This clinical trial studies the following conditions: Atrial Fibrillation.

What interventions are being tested in trial NCT05111015?

The interventions under investigation include: Open Concomitant Surgical Ablation Procedures (DEVICE), Hybrid (Convergent) Ablation Procedures (DEVICE), AtriCure Hybrid Totally Thoracoscopic Ablation Procedures (DEVICE), AtriCure LAA Exclusion Procedures (DEVICE).

Who is sponsoring clinical trial NCT05111015?

This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05111015 being conducted?

This trial has 20 study locations across Alabama, Arkansas, California, Colorado, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05111015's enrollment target sits among peer trials

10,000 12th of 202 higher than 191 of 202 other Atrial Fibrillation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00160771 · 10,000 participants

    Biomechanics/Motion Analysis Laboratory Data Bank

  • NCT00896935 · 10,000 participants

    Arizona Cancer Center Biospecimen Repository

  • NCT00898235 · 10,000 participants

    Collection of Samples and Clinical Data From Patients With Amyloid Diseases

  • NCT00992303 · 10,000 participants

    Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

More recruiting context for NCT05111015

Source: ClinicalTrials.gov NCT05111015, the US trial registry maintained by the National Library of Medicine. NCT05111015 (large enrollment · wide site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.